News Briefs

✦ Manufacturer prices for insulin in the United States were “considerably” — often five or 10 times — higher than those in other Organisation for Economic Co-operation and Development countries, according to a new report from researchers at RAND Corp. The average price per unit across all types of insulin in the United States was $98.70, the report said, while other countries would have paid a fraction of that for the same insulins. In addition, “the analysis suggests that U.S. insulin prices would still have been considerably higher — about four times higher — than those in other countries even when accounting for potential rebates,” researchers wrote. View the report at https://bit.ly/3izlH6k.

✦ CVS Health Corp. is offering Whil — a “digital training platform” focused on workplace mindfulness, stress resilience, sleep, and mental and emotional wellbeing — to its PBM clients as part of its Points Solutions Management offerings for employers. “Employers and other plan sponsors are increasingly looking for innovative tools to help people manage their mental health, especially in light of the COVID-19 pandemic,” Sree Chaguturu, M.D., CVS Caremark’s chief medical officer, said in an Oct. 1 news release. “Whil’s commitment to clinical evaluation and research aligns with our focus on helping our clients include clinically effective digital point solutions as part of their benefits packages.” Visit https://bwnews.pr/3d8T8vB.

0

0

0 Comments

0

0

• Radar on Drug Benefits